Researchers from the Walter and Eliza Hall Institute (WEHI)in Australia have found a new way to predict a subset of patients ...
Nuvectis Pharma shares fell steeply after updated data from its early-stage study evaluating NXP800 to treat an aggressive type of ovarian cancer showed that a change in the dosing schedule only ...
Nuvectis Pharma (NASDAQ:NVCT) lost ~45% on Thursday after the oncology-focused biotech announced data from an ongoing ...
Followed categories will be added to My News. In a world-first finding, Melbourne researchers investigated a major “blind ...
Clemson University's first African American woman to become a tenured professor at Clemson University's College of Education ...
LEANNE Battersby looks set to be left rattled in the coming days on Coronation Street. Over the past few months, fans of the ...
However, it turned out that the young woman was actually experiencing a sneaky symptom of cancer. According to Bowel Cancer ...
ATA 2024 spotlighted new research to help endocrinologists manage the subsequent fertility, bone health, and cardiovascular ...
When Ellie Wilcock was hit by sharp pains in her abdomen and sudden bouts of fatigue in 2022, she blamed it on a urinary ...
ImmunoGen, Inc. has announced that its platinum-resistant ovarian cancer drug ELAHERE (mirvetuximab soravtansine-gynx) has been granted FDA accelerated approval. This first FDA antibody-drug ...
A small clinical trial shows promising results for patients with triple-negative breast cancer who received an ...
Trump Taps Matt Gaetz for Attorney General, a Provocative Move President-elect Trump plans to nominate the Florida congressman, among a flurry of personnel announcements as Republicans neared ...